Sotera Health (NASDAQ:SHC) Upgraded at The Goldman Sachs Group

Sotera Health (NASDAQ:SHC - Get Free Report) was upgraded by analysts at The Goldman Sachs Group from a "neutral" rating to a "buy" rating in a report released on Monday, Marketbeat Ratings reports. The firm currently has a $17.00 price target on the stock, up from their previous price target of $14.00. The Goldman Sachs Group's price objective suggests a potential upside of 29.47% from the stock's previous close.

Other research analysts have also recently issued research reports about the stock. Barclays cut their target price on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating for the company in a research note on Thursday, April 10th. Piper Sandler reduced their price objective on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 23rd. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, Sotera Health has a consensus rating of "Moderate Buy" and a consensus target price of $15.80.

Sotera Health Price Performance

Shares of Sotera Health stock traded down $0.10 during midday trading on Monday, hitting $13.13. 780,945 shares of the company were exchanged, compared to its average volume of 1,195,000. The firm has a 50 day simple moving average of $11.45 and a 200-day simple moving average of $12.95. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The firm has a market cap of $3.73 billion, a P/E ratio of 52.52 and a beta of 1.88. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. The company had revenue of $254.52 million during the quarter, compared to analysts' expectations of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The business's revenue was up 2.6% on a year-over-year basis. During the same period last year, the business earned $0.13 earnings per share. Research analysts forecast that Sotera Health will post 0.61 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Deutsche Bank AG lifted its stake in shares of Sotera Health by 1,902.2% during the first quarter. Deutsche Bank AG now owns 165,605 shares of the company's stock valued at $1,931,000 after acquiring an additional 157,334 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Sotera Health by 5.1% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,415,282 shares of the company's stock valued at $16,502,000 after purchasing an additional 68,087 shares during the period. XTX Topco Ltd bought a new position in shares of Sotera Health in the 1st quarter valued at about $602,000. Victory Capital Management Inc. grew its position in shares of Sotera Health by 5.7% during the 1st quarter. Victory Capital Management Inc. now owns 57,655 shares of the company's stock worth $672,000 after buying an additional 3,106 shares during the period. Finally, Principal Financial Group Inc. raised its stake in shares of Sotera Health by 0.3% during the first quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock worth $4,109,000 after buying an additional 1,037 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company's stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.